These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30528453)

  • 1. Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence.
    Xu W; Monaco G; Wong EH; Tan WLW; Kared H; Simoni Y; Tan SW; How WZY; Tan CTY; Lee BTK; Carbajo D; K G S; Low ICH; Mok EWH; Foo S; Lum J; Tey HL; Tan WP; Poidinger M; Newell E; Ng TP; Foo R; Akbar AN; Fülöp T; Larbi A
    EBioMedicine; 2019 Jan; 39():44-58. PubMed ID: 30528453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of gamma delta T cells in humans.
    De Rosa SC; Andrus JP; Perfetto SP; Mantovani JJ; Herzenberg LA; Herzenberg LA; Roederer M
    J Immunol; 2004 Feb; 172(3):1637-45. PubMed ID: 14734745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
    Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
    Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
    J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.
    Michishita Y; Hirokawa M; Guo YM; Abe Y; Liu J; Ubukawa K; Fujishima N; Fujishima M; Yoshioka T; Kameoka Y; Saito H; Tagawa H; Takahashi N; Sawada K
    Int J Hematol; 2011 Sep; 94(3):230-240. PubMed ID: 21858446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection.
    Pihl RMF; Smith-Mahoney EL; Olson A; Yuen RR; Asundi A; Lin N; Belkina AC; Snyder-Cappione JE
    J Infect Dis; 2024 May; 229(5):1317-1327. PubMed ID: 38390982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
    Negash M; Tsegaye A; Wassie L; Howe R
    BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.
    Bian Z; Xu LP; Fu Q; Huo M; Liu L; Zhao X; Huang XJ; Liu J
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):252-259. PubMed ID: 29061533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
    Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
    Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
    Wistuba-Hamprecht K; Martens A; Haehnel K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Demuth I; Steinhagen-Thiessen E; Larbi A; Schilling B; Schadendorf D; Wolchok JD; Blank CU; Pawelec G; Garbe C; Weide B
    Eur J Cancer; 2016 Sep; 64():116-26. PubMed ID: 27400322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
    Kress E; Hedges JF; Jutila MA
    Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant phenotypes of circulating γδ-T cells may be involved in the onset of systemic lupus erythematosus.
    Yuan S; Wang C; Zeng Y; Li J; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Xu Y; Yu N; Cai X
    Lupus; 2024 May; 33(6):587-597. PubMed ID: 38506324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function.
    Rodin W; Szeponik L; Rangelova T; Tamiru Kebede F; Österlund T; Sundström P; Hogg S; Wettergren Y; Cosma A; Ståhlberg A; Bexe Lindskog E; Quiding Järbrink M
    Cancer Immunol Immunother; 2024 Jul; 73(9):174. PubMed ID: 38953978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
    Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
    J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vδ2+ and α/ß T cells show divergent trajectories during human aging.
    Tan CT; Wistuba-Hamprecht K; Xu W; Nyunt MS; Vasudev A; Lee BT; Pawelec G; Puan KJ; Rotzschke O; Ng TP; Larbi A
    Oncotarget; 2016 Jul; 7(29):44906-44918. PubMed ID: 27384987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human γδ TCR Repertoires in Health and Disease.
    Fichtner AS; Ravens S; Prinz I
    Cells; 2020 Mar; 9(4):. PubMed ID: 32225004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.
    Zheng NN; McElrath MJ; Sow PS; Mesher A; Hawes SE; Stern J; Gottlieb GS; De Rosa SC; Kiviat NB
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):92-100. PubMed ID: 21423026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human Vδ2
    Davey MS; Willcox CR; Hunter S; Kasatskaya SA; Remmerswaal EBM; Salim M; Mohammed F; Bemelman FJ; Chudakov DM; Oo YH; Willcox BE
    Nat Commun; 2018 May; 9(1):1760. PubMed ID: 29720665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive activity of Vδ2
    Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
    Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.